ArticleBMC research notes2011

Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro.

Eric Abhold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.